Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention

Neurobiology of Aging

Volumn 35, Issue 6, 2014, Pages 1252-1254

  Engelman, Corinne D ^a   Koscik, Rebecca L ^a   Jonaitis, Erin M ^a   Hermann, Bruce P ^a   La Rue, Asenath ^a   Sager, Mark A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; Cognition; Family history; Longitudinal; Memory; TREM2

Indexed keywords

MEMBRANE PROTEIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; TREM2 PROTEIN, HUMAN;

ADULT; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE REGISTRY; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROPSYCHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TREM2 GENE; UNITED STATES; ALLELE; COGNITION DISORDERS; GENETICS; HETEROZYGOTE; ONSET AGE; PHYSIOLOGY; PSYCHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA;

AGE OF ONSET; ALLELES; ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; FEMALE; GENETIC VARIATION; HETEROZYGOTE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; REGISTRIES;

EID: 84903362979     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.11.013     Document Type: Article

References (15)

1. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement. 2013, 9:208-245.
2. Benitez B.A., Cooper B., Pastor P., Jin S.C., Lorenzo E., Cervantes S., Cruchaga C. TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Neurobiol. Aging 2013, 34:1711.e15-1711.e17. 10.1016/j.neurobiolaging.2012.12.018.
3. Dowling N.M., Hermann B., La Rue A., Sager M.A. Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease. Neuropsychology 2010, 24:742-756. 10.1037/a0020176.
4. Engelman C.D., Koscik R.L., Jonaitis E.M., Okonkwo O.C., Hermann B.P., La Rue A., Sager M.A. Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention. J.Alzheimers Dis 2013, 10.3233/JAD-130482.
5. Giraldo M., Lopera F., Siniard A.L., Corneveaux J.J., Schrauwen I., Carvajal J., Munoz C., Ramirez-Restrepo M., Gaiteri C., Myers A.J., Caselli R.J., Kosik K.S., Reiman E.M., Huentelman M.J. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol. Aging 2013, 34:2077.e11-2077.e18. 10.1016/j.neurobiolaging.2013.02.016.
6. Gonzalez Murcia J.D., Schmutz C., Munger C., Perkes A., Gustin A., Peterson M., Ebbert M.T., Norton M.C., Tschanz J.T., Munger R.G., Corcoran C.D., Kauwe J.S. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study. Neurobiol. Aging 2013, 10.1016/j.neurobiolaging.2013.06.004.
7. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., Hazrati L., Collinge J., Pocock J., Lashley T., Williams J., Lambert J.C., Amouyel P., Goate A., Rademakers R., Morgan K., Powell J., St George-Hyslop P., Singleton A., Hardy J. TREM2 variants in Alzheimer's disease. New Engl. J. Med 2012, 10.1056/NEJMoa1211851.
8. Jonsson T., Stefansson H., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., Rujescu D., Hampel H., Giegling I., Andreassen O.A., Engedal K., Ulstein I., Djurovic S., Ibrahim-Verbaas C., Hofman A., Ikram M.A., van Duijn C.M., Thorsteinsdottir U., Kong A., Stefansson K. Variant of TREM2 associated with the risk of Alzheimer's disease. New Engl. J. Med 2012, 10.1056/NEJMoa1211103.
9. La Rue A., Hermann B., Jones J.E., Johnson S., Asthana S., Sager M.A. Effect of parental family history of Alzheimer's disease on serial position profiles. Alzheimers Dement. 2008, 4:285-290.
10. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984, 34:939-944.
11. Pottier C., Wallon D., Rousseau S., Rovelet-Lecrux A., Richard A.C., Rollin-Sillaire A., Frebourg T., Campion D., Hannequin D. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. J.Alzheimers Dis. 2013, 35:45-49. 10.3233/JAD-122311.
12. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575. 10.1086/519795.
13. Sager M.A., Hermann B., La Rue A. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. J.Geriatr. Psychiatry Neurol. 2005, 18:245-249.
14. Slooter A.J., Cruts M., Kalmijn S., Hofman A., Breteler M.M., Van Broeckhoven C., van Duijn C.M. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol. 1998, 55:964-968.
15. Thambisetty M., An Y., Tanaka T. Alzheimer's disease risk genes and the age-at-onset phenotype. Neurobiol. Aging 2013, 34:2696.e1-2696.e5. 10.1016/j.neurobiolaging.2013.05.028.